FLF:SG ‘The next frontier of longevity – human healthspan resilience’
Tina Woods on evidence-based practices, government policies on public health and why Singapore is a model for longevity initiatives.
Founders Longevity Forum Singapore is only a couple of months away! Poised to bring together global leaders in longevity science, the two-day event will focus on the latest research and applications in healthy aging. With the growing global focus on longevity, this gathering provides a dynamic platform to showcase innovations and ignite partnerships that advance the pursuit of extended healthspan and vitality, and will also highlight Singapore’s role as a hub for innovation in tackling aging-related challenges.
Tina Woods , Executive Director of the International Institute of Longevity , will be a key participant at the event. Known for her dedication to advancing global longevity strategies, Woods has been instrumental in fostering collaborations between researchers, technology developers and healthcare providers, and her expertise will add depth to discussions on how to create scalable, evidence-based solutions for aging populations worldwide.
My take on this: Tina Woods’ presentation with Jacqueline Poh , Managing Director of the Singapore Economic Development Board (EDB) , on Governments Leading the Way is set to be a Forum highlight. Ahead of February’s Forum, we sat down with Tina to get her thoughts on longevity clinics, the need for international standards and regulations and more.
Tina Woods on 'a coming together'
It’s really important that we come together as an industry, especially as we’re seeing a huge amount of interest and investment in the global health and wellness sector, and longevity is a core part of that bigger pie, especially at a time when we need more rigor, best practice, and standards, guidelines and protocols to ensure that we’re operating as we need to. We need to ensure we’re delivering real value to people and not damaging them either, because there’s a lot of new entrants into the space, which may not be as robust in their approach as really is needed.
Recommended by LinkedIn
It’s like every industry cycle – there’s a point where the early innovators need to start getting together in a room and thrashing out standards so they can all compete on the on the same baseline of rules. Longevity is a very much an international industry, and what’s great to see is that there’s a huge interest in collaboration. We need to bring that science and technology of longevity into the mainstream debate, both with government, investors and, of course, the general public. There’s room for everybody, and there’s plenty of room to grow.
Gain valuable insights from Tina Woods on longevity clinics, global longevity trends and more. Watch the full video HERE. Plus, Discover how Proton Intelligence 's breakthrough in continuous potassium monitoring could revolutionize health tracking and patient care right HERE.
Sign up now to express your interest in joining the Founders Longevity Forum Singapore. Find out more about the event from Founders Forum Group .
Thank you for reading! If you enjoyed this article, it would mean a lot to me if you could subscribe and share it on LinkedIn!
Management Consultant
3dWe must be careful in our race for longevity that we don't loose our ability for critical self reflection and our respect and connection to each other...
CEO @ Dr. Bligh LLC | Founder
3dWe do not need to look back very far to the standards of care and protocols used during the COVID pandemic that ended up killing thousands of patients needlessly. And the vaccine injuries are growing day by day as we are seeing the Excess death rates in young people is just starting to rise. Standards are needed by group “think” can lead to bad results. And it if often the independent thinkers that come up with the best treatments and cures. Putting all your faith in big pharma and big governments may not be the best path!
Professor of Public Health, University of Illinois at Chicago; Co-Founder and Chief Scientist at Lapetus Solutions; Chief Scientist at Wealthspan; Board of Directors (former), American Federation for Aging Research
3dExcellent news. Great approach with a focus on standards.
Owner, Koolkreations Inc.
3d-IF we could just get back what we had prior to December 16, 1811, now no one even knows what Cathedrals... are-
Management Consultant
3dFortunes being wasted on worldwide duplicated effort. A great example is Rapamycin..how many labs and how much time, effort and cost is being invested in this product. It reminds me of David Sinclairs efforts with Resveratrol..what we need is some coordinated joined up thinking and less endless, self congratulatory conferences.